Results 211 to 220 of about 1,164,546 (387)

A UK study: vocational experiences of young adults with juvenile idiopathic arthritis

Pediatric Rheumatology Online Journal, 2019
Laura E. Lunt, Ailsa Bosworth, Matthew Bezzant, Karen Walker-Bone, Kimme L. Hyrich, Wendy Thomson, Janet E. McDonagh, Suzanne M. M. Verstappen   +7 more
doaj   +1 more source

Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis [PDF]

, 2004
Sylvia Dörr, Nadine Lechtenböhmer, Rolf Rau, G. Herborn, Ulf Wagner, Bertram Müller‐Myhsok, I. Hansmann, Gernot Keyszer   +7 more
openalex   +1 more source

Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment [PDF]

, 2020
Joanna Wielińska, Katarzyna Kolossa, Jerzy Świerkot, Marta Dratwa, Milena Iwaszko, Bartosz Bugaj, Barbara Wysoczańska, Monika Chaszczewska-Markowska, Sławomir Jeka, Katarzyna Bogunia‐Kubik   +9 more
openalex   +1 more source

The etiology of rheumatoid arthritis.

Journal of Autoimmunity, 2020
H. Scherer, T. Häupl, G. Burmester
semanticscholar   +1 more source

Performance Characteristics of Anti‐Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta‐Analysis

Arthritis Care &Research, Accepted Article.
Background Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti‐collagen II (anti‐Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick, Marcela A. Ferrada, Alice Fike, Kaitlin A. Quinn, Benjamin A. Turturice, Casey Stein, Peter C Grayson   +6 more
wiley   +1 more source

Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions [PDF]

, 2004
Diane C. Berry
openalex   +1 more source

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis [PDF]

, 2021
Alison Hammond, Yeliz Prior, Sarah Cotterill, Chris Sutton, Elizabeth Camacho, Calvin Heal, Jo Adams, Yvonne Hough, Terence W O’Neill, Jill Firth   +9 more
openalex   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, Accepted Article.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) network investigators   +14 more
wiley   +1 more source

Causal graph-based analysis of genome-wide association data in rheumatoid arthritis [PDF]

, 2011
Alexander V. Alekseyenko, Nikita I. Lytkin, Jizhou Ai, Bo Ding, Leonid Padyukov, Constantin Aliferis, Alexander Statnikov   +6 more
openalex   +1 more source

Comparison of Rheumatoid Arthritis Patients’ 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates [PDF]

, 2022
Laetitia Diep, Vincent Barbier, Marie Doussière, Estelle Touboul, Claire Jesson, V. Deprez, Jean-Marc Sobhy-Danial, Patrice Fardellone, Vincent Goëb   +8 more
openalex   +1 more source